ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.
| Revenue (TTM) | $2.18B |
| Gross Profit (TTM) | $879.02M |
| EBITDA | $375.55M |
| Operating Margin | 10.50% |
| Return on Equity | 2.79% |
| Return on Assets | 2.73% |
| Revenue/Share (TTM) | $87.79 |
| Book Value | $87.62 |
| Price-to-Book | 1.94 |
| Price-to-Sales (TTM) | 1.97 |
| EV/Revenue | 2.386 |
| EV/EBITDA | 18.14 |
| Quarterly Earnings Growth (YoY) | -46.90% |
| Quarterly Revenue Growth (YoY) | 4.40% |
| Shares Outstanding | $25.01M |
| Float | $24.56M |
| % Insiders | 1.75% |
| % Institutions | 116.19% |
Volatility is currently expanding
SAN CLEMENTE, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 2026 Jefferies Global Healthcare Conference being held in London, November 15-18, 2026.
SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2026 earnings release and conference call.
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.
ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.
SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ICUI and any ticker you trade — then tracks every position and per-strategy win rate.
